Good morning :)

Prashant Jain Portfolio: Latest Stocks, Portfolio and Shareholdings in 2026

Prashant Jain is the co-founder and Chief Investment Officer of 3P Investment Managers. Before starting 3P in 2022, he served as Chief Investment Officer at HDFC Mutual Fund for nearly two decades and is the only fund manager in India to have continuously managed a single scheme for over 28 years. He has a publicly disclosed net worth of over Rs. 273 cr. based on corporate shareholding filings as of 31st December, 2025. This article covers his disclosed stock holdings, portfolio composition, investment approach, and sector exposure, based on publicly available data.

Latest Prashant Jain Stock Portfolio & Holdings (2026)

Prashant Jain Portfolio Stock Screener

Prashant Jain Portfolio Stock Screener: Analyse & Filter Indian Stocks on Tickertape

Created by

@tickertapetickertape

Showing 1 - 4 of 4 results

last updated at 9:45 PM IST 
NameStocks (4)↓↓Sub-SectorSub-Sector↓↓Market CapMarket Cap↓↓Close PriceClose Price↓↓PE RatioPE Ratio↓↓1D Return1D Return↓↓1M Return1M Return↓↓6M Return6M Return↓↓1Y Return1Y Return↓↓PB RatioPB Ratio↓↓Return on EquityReturn on Equity↓↓ROCEROCE↓↓Dividend YieldDiv Yield↓↓Debt to EquityDebt to Equity↓↓Volatility vs NiftyVolatility vs Nifty↓
1.Astrazeneca Pharma India LtdASTRAZENPharmaceuticalsPharmaceuticals22,406.2522,406.258,962.508,962.50193.59193.591.851.856.186.18-0.88-0.8811.9411.9429.0929.0915.6215.6219.3619.360.360.360.050.052.142.14
2.Nocil LtdNOCILCommodity ChemicalsCommodity Chemicals2,803.512,803.51167.85167.8550.4050.401.271.27-10.26-10.26-4.36-4.36-8.71-8.711.591.595.945.944.084.080.890.890.010.012.512.51
3.Indag Rubber LtdINDAGAuto PartsAuto Parts235.59235.5989.7589.7536.0836.080.800.80-3.39-3.39-32.85-32.85-34.56-34.561.021.022.832.832.912.912.672.670.040.042.812.81
4.Kahan Packaging LtdKAHANPackagingPackaging11.4211.4242.0042.009.769.760.000.00-4.55-4.55-27.59-27.59-40.00-40.001.161.1612.1612.1620.2120.21--0.810.815.555.55
Edit Filters

Analyse Prashant Jain Portfolio Stocks Further

Visit 'Prashant Jain Portfolio' ScreenerScreener

Disclaimer: Please note that the above table is for informational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.

Selection criteria: The table contains the publicly disclosed Prashant Jain investment portfolio as on 21st May 2026. Stocks are sorted by market capitalisation, highest to lowest.

​​

Prashant Jain's Bulk and Block Deals

Bulk and block deals improve market transparency and explain sharp changes in stock volumes. These disclosures help track where large investors deploy capital and which sectors attract or lose interest over time. Analysts often review such deals to understand portfolio shifts and changing market sentiment.


  1. Open Market Movers on Tickertape
  2. Under Party, type Shiv Nadar
  3. Select the relevant Category and Transaction Type

The results show Prashant Jain’s latest bulk and block deals. The platform also allows date filtering to review historical transactions and identify patterns over time.

Investor Profile – Prashant Jain

Prashant Jain completed his B.Tech in Mechanical Engineering from IIT Kanpur and his PGDM from IIM Bangalore in 1991. He began his career in the equity research team at SBI Mutual Fund, entering the world of investment management at a time when India's capital markets were still maturing. In 1993, he moved to set up the 20th Century Mutual Fund, which was subsequently acquired by Zurich Financial Services and renamed Zurich India Mutual Fund, and later taken over by HDFC Mutual Fund in 2003. In 2022, he co-founded 3P Investment Managers along with Ashwani Kumar and Sharad Mohnot, with the firm's guiding philosophy of Prudence, Patience, and Performance.

  1. Full name: Prashant Jain
  2. Education: B.Tech, Mechanical Engineering, IIT Kanpur; PGDM, IIM Bangalore (1991)
  3. Current role: Co-Founder and Chief Investment Officer, 3P Investment Managers (founded 2022)
  4. Previous role: Chief Investment Officer, HDFC Asset Management Company (2004 to 2022)
  5. Career start: 1991, SBI Mutual Fund (equity research)
  6. Total investment experience: Over 32 years in Indian equities
  7. Disclosed portfolio value: Over Rs. 273 cr. (as of Q3 2025, quarter ending 31st December, 2025)
  8. Investment philosophy: 3P framework: Prudence in portfolio construction, Patience with businesses and markets, Performance as an outcome of process

Prashant Jain is known for staying invested in conviction ideas through difficult market phases and for his willingness to back PSU stocks and contrarian sector calls when most institutional investors were avoiding them. His bullish stance on PSU stocks from 2020 onwards, which drew significant criticism at the time, eventually proved correct when the PSU index delivered a CAGR of 44.5% from October 2020 to August 2022. His personal stock holdings reflect a similar pattern of concentrated, conviction-based positions in businesses he understands well.



Overview of Stocks in Prashant Jain's Portfolio

AstraZeneca Pharma India Ltd

AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the manufacture, distribution, and marketing of pharmaceutical products in India. It is a subsidiary of AstraZeneca Pharmaceuticals AB. The company focuses on cardiovascular, renal and metabolic conditions, oncology, respiratory and inflammatory diseases, and rare diseases.

NOCIL Ltd

NOCIL Limited is India's largest manufacturer of rubber chemicals, part of the Arvind Mafatlal Group. Incorporated in 1961, the company manufactures a range of products, including accelerators, antidegradants, antioxidants, pre-vulcanisation inhibitors, and post-vulcanisation stabilisers, sold under the PILFLEX, PILNOX, PILCURE, and PILGARD brands.

Indag Rubber Ltd

Indag Rubber Limited, incorporated in 1978, is a pioneer in the introduction of cold retreading technology in India and one of the leading manufacturers of tyre retreading materials. Founded as a joint venture between the Khemka Group and Bandag Inc. (USA), the company supplies retreading materials, including cured tread rubber, curing envelopes, bonding cushion gum, and allied products across a network of retreaders serving fleet operators of trucks, buses, and commercial vehicles.

Kahan Packaging Ltd

Kahan Packaging Limited was incorporated in 2013 and commenced commercial production in 2016. The company manufactures and supplies polypropylene and HDPE woven fabric, laminated and unlaminated woven sacks, PP woven bags, and printed laminates for flexible packaging.

Prashant Jain Portfolio Composition

The following table shows the publicly disclosed holdings of Prashant Jain as per corporate shareholding data filed for the quarter ending 31st December, 2025.

Stock Name Holding Value (in cr.) Quantity Held Holding Percent (%)
AstraZeneca Pharma India Ltd 242.90 2,76,000 1.10%

How to Invest in Prashant Jain Portfolio Stocks?

Here's how you can invest in Prashant Jain's portfolio stocks using Tickertape:

  1. Create an account on Tickertape or log in to your existing account.
  2. Open Prashant Jain Portfolio Screener
  3. Filter stocks using 200+ parameters, including financials, fundamentals, valuations, and technicals, to evaluate each holding based on your investment criteria.
  4. Once you have decided on a stock, you can place a buy order through your linked broker account directly from the Tickertape platform.

You can stay updated on any changes to Prashant Jain's holdings using Tickertape Alerts. Track your investments and monitor performance from your portfolio now!

How to Invest in Prashant Jain Portfolio Stocks?

Here's how you can invest in Prashant Jain's portfolio stocks using Tickertape:

  1. Create an account on Tickertape or log in to your existing account.
  2. Open Prashant Jain Portfolio Screener
  3. Filter stocks using 200+ parameters, including financials, fundamentals, valuations, and technicals, to evaluate each holding based on your investment criteria.
  4. Once you have decided on a stock, you can place a buy order through your linked broker account directly from the Tickertape platform.

You can stay updated on any changes to Prashant Jain's holdings using Tickertape Alerts. Track your investments and monitor performance from your portfolio now!

Prashant Jain's Investment Strategy

Contrarian Positioning with Deep Conviction

Prashant Jain is widely known for his willingness to hold positions that are out of consensus. His most publicised call was his bullish stance on PSU stocks from 2018 onwards, during a period when public sector companies were broadly avoided by most institutional investors.

Long-Term Holding with Low Churn

Prashant Jain's approach has consistently been to identify businesses he believes in and hold them through market cycles, rather than rotating actively. His 28-year management of the HDFC Balanced Advantage Fund is the clearest expression of this patience.

Focus on Reasonably Valued Businesses

The 3P framework places Prudence first, defining it as investing in businesses at reasonable valuations rather than chasing market-favourite growth stocks at elevated multiples. Prashant Jain has historically been sceptical of sectors and stocks where market narratives have run far ahead of underlying earnings.

Pharma and Healthcare as a Structural Long-Term Bet

The single largest position in Prashant Jain's disclosed portfolio is AstraZeneca Pharma India, which accounts for over 88% of the total disclosed value. AstraZeneca Pharma India gives exposure to oncology, cardiovascular, respiratory, and rare disease therapy areas in one of the world's fastest-growing pharmaceutical markets.

Learnings From Prashant Jain's Portfolio

Conviction Requires Patience

Prashant Jain's PSU call took more than two years to play out and drew sustained criticism during the waiting period. The portfolio lesson is that having a correct thesis is only part of the requirement. The harder part is maintaining the position amid market and peer pressure, while the thesis has not yet been validated by price.

Niche Businesses May Offer High Potential

NOCIL (India's largest rubber chemicals manufacturer) and Indag Rubber (a pioneer in tyre retreading materials) are not household names and receive minimal analyst coverage compared to large-cap stocks. Prashant Jain's willingness to hold small, niche industrial companies reflects the principle that market attention and investment quality are not the same.

Process Matters More Than Predictions

The 3P philosophy of Prudence, Patience, and Performance positions performance as an outcome of process rather than a goal in itself. Prashant Jain has spoken consistently about avoiding speculative positioning and focusing on sustainable earnings businesses.

Concentration in High-Conviction Ideas

Prashant Jain's disclosed portfolio is highly concentrated, with one stock accounting for almost 89% of the disclosed value. This is not an accident. His fund management career, particularly at 3P, has been built around a focused, high-conviction portfolio approach.

Install the Tickertape app and enjoy a more hands-on investing experience
  • portfolio-iconReceive real-time market alerts for timely decisions
  • portfolio-iconMonitor your portfolio from the palm of your hands
  • portfolio-iconWatchlist stocks and mutual funds to stay updated
Download Now

Prashant Jain Portfolio: Sector Allocation

Pharmaceuticals and Healthcare

AstraZeneca Pharma India Ltd represents the healthcare and pharmaceuticals exposure in Prashant Jain's disclosed portfolio. The company operates across oncology, cardiovascular, respiratory, and rare disease therapy areas as an Indian subsidiary of the global AstraZeneca group.

Chemicals

NOCIL Ltd provides exposure to the speciality rubber chemicals segment. As India's largest rubber chemicals manufacturer, the company serves the tyre industry and other rubber processing industries. The holding reflects a view on India's industrial and automotive sector growth, where rubber chemicals are a recurring consumable input across the supply chain.

Auto Components and Industrial Materials

Indag Rubber Ltd adds exposure to the tyre retreading materials segment within the broader auto components and industrial space. The company provides a cost-effective alternative to new tyre purchases for commercial fleet operators, with demand linked to India's freight and transport activity.

Packaging

Kahan Packaging Ltd provides a small exposure to the flexible and woven packaging segment. The company serves B2B manufacturers across agro-pesticides, cement, chemicals, fertilisers, and food sectors. Given the filing-awaited status and nominal holding size, this is a negligible position in the overall disclosed portfolio

Conclusion

Prashant Jain's portfolio reflects a contrarian, conviction-driven investment approach applied consistently across his three-decade career. The portfolio is heavily weighted toward AstraZeneca Pharma India, which accounts for the bulk of disclosed value, alongside two smaller niche industrial positions in rubber chemicals and tyre retreading.

It is important to remember that the public disclosure data captures only stakes above the 1% threshold and does not represent a complete picture of Prashant Jain's personal wealth or his investment views at 3P Investment Managers. The strategies managed at 3P on behalf of clients are separate from his personally disclosed holdings. Investment decisions should be based on independent research, individual financial goals, and risk tolerance.

For independent stock analysis, investors can use the Tickertape Stock Screener to evaluate these stocks on 200+ parameters, or track recent market transactions through Tickertape Market Movers.

Popular Stock Collections

Popular Mutual Fund Collections

Frequently Asked Questions About the Prashant Jain Portfolio

  1. Who is Prashant Jain?

    Prashant Jain is the co-founder and Chief Investment Officer of 3P Investment Managers, a firm he established in 2022 after nearly two decades as Chief Investment Officer at HDFC Mutual Fund. He is the only fund manager in India to have continuously managed a single scheme for over 28 years and the only one to have managed over Rs. 1 lakh cr. in equity assets.

  2. What does the Prashant Jain portfolio 2025 include?

    As per corporate shareholding data filed for the quarter ending 31st December, 2025, Prashant Jain's publicly disclosed portfolio includes AstraZeneca Pharma India Ltd (1.10%, Rs. 242.9 cr.), NOCIL Ltd (1.12%, Rs. 27.5 cr.), Indag Rubber Ltd (1.05%, Rs. 2.6 cr.), and a sub-1% position in Kahan Packaging Ltd for which the December 2025 filing was still awaited at the time of data collection.

    Disclaimer: This information is for educational purposes only and should not be considered investment advice.

  3. What stocks does Prashant Jain hold?

    As per the latest available public shareholding disclosures, Prashant Jain holds the following stocks:
    1. Kahan Packaging Ltd
    2. Astrazeneca Pharma India Ltd
    3. Nocil Ltd
    4. Indag Rubber Ltd

    Disclaimer: This information is for educational purposes only and should not be considered investment advice.

  4. What is the net worth of Prashant Jain?

    Based on corporate shareholding data filed for 31st December, 2025, Prashant Jain's disclosed public equity holdings are valued at over Rs. 273 cr. This figure covers only personal direct stakes in listed Indian companies at or above the 1% threshold. It does not include any assets managed at 3P Investment Managers on behalf of clients.

  5. What is Prashant Jain's investment philosophy?

    Prashant Jain's investment philosophy is built around the 3P framework: Prudence in portfolio construction using reasonably valued businesses, Patience with businesses and markets, and Performance as an outcome of process rather than a goal in itself. He focuses on investing in fundamentally strong, scalable businesses at reasonable valuations with a long-term holding horizon, low portfolio churn, and avoidance of speculative positioning.

  6. Who is Prashant Jain fund manager?

    Prashant Jain is a veteran Indian equity fund manager and the Founder & Chief Investment Officer of 3P Investment Managers. He earlier worked at HDFC Mutual Fund, where he managed some of India’s largest equity schemes and built a long track record in value-oriented investing.

  7. What sectors does Prashant Jain invest in?

    Based on his publicly disclosed personal shareholding data, Prashant Jain's portfolio spans four sectors: pharmaceuticals and healthcare through AstraZeneca Pharma India Ltd, rubber chemicals through NOCIL Ltd, tyre retreading materials through Indag Rubber Ltd, and flexible packaging through a negligible position in Kahan Packaging Ltd.

    Disclaimer: This information is for educational purposes only and should not be considered investment advice.

  8. What is Prashant Jain's largest holding?

    As of the quarter ending 31st December 2025, Prashant Jain's largest disclosed holding is AstraZeneca Pharma India Ltd, in which he holds 2,76,000 shares, representing a 1.10% stake valued at approximately Rs. 242.9 cr. This holding accounts for over 88% of the total disclosed portfolio value.

  9. What does the 3P India Equity Fund portfolio include?

    As per corporate shareholding data filed for 31st March 2026, people matching 3P India Equity Fund publicly hold 13 stocks with a net worth of over ₹2,570.7 cr. These are shares held by the 3P India Equity Fund portfolio based on shareholding data filed with the exchanges. The latest quarter may have missing data, as not all companies may have reported their shareholding details yet.

  10. What is Prashant Jain's new venture?

    Prashant Jain’s new venture is 3P Investment Managers, an India-focused investment management firm he co-founded after his long tenure at HDFC Mutual Fund.

Disclaimer: This article is for informational purposes only. The content of the article, including securities/investment products mentioned, if any, should not in any manner be construed as investment advice, recommendation, offer, or solicitation to buy/hold/sell any securities/investment products. The securities quoted, if any, are for illustration only and are not recommendatory. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered financial advisor before investing.